Corrigendum: Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors
Francesca Arezzo, Gaia Giannone, Daniele Castaldo, Giulia Scotto, Valentina Tuninetti, Margherita Turinetto, Michele Bartoletti, Serafina Mammoliti, Grazia Artioli, Giorgia Mangili, Vanda Salutari, Domenica Lorusso, Gennaro Cormio, Vera Loizzi, Claudio Zamagni
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEndometrial and Cervical Cancer Treatments · Management of metastatic bone disease · Cancer Genomics and Diagnostics
In the published article, there was an error in affiliation 15. Instead of “Department of Oncology, Regina Elena National Cancer Institute, Rome, Italy”, it should be “Department of Oncology, IRCCS Regina Elena National Cancer Institute-Rome, Italy.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.